By Vikki Blevins When you are an advocate for cancer screening and prevention in a state with the nation’s highest cancer mortality rate, you must be an optimist in order to keep pushing forward. The fact is, when it comes to Kentucky and cancer, there is reason to believe a healthier future lies ahead. Some…
New Pharmacy Arrangements Cause Harm to Drug Program
By Kyle Keeney, PhD One of the most important functions of our elected leaders in Washington is ensuring that the programs they create are working as intended. Without proper oversight and periodic maintenance, even the most well-intentioned of programs can run astray. Such is the case with 340B, a little-known health care program Congress created…
Kentucky-based Start-up is Simplifying HealthCare – One Payment at a Time
By Raffi Kayat The total US healthcare expenditure hit $3.6 trillion in 2019, yet 90% of healthcare providers still use paper checks and manual processes for payment collections. Recognizing an opportunity, we at borderless™, a Louisville-based payments company, launched a healthcare initiative to provide simple, contactless and affordable digital payments. Healthcare E-commerce is on the…
Keeping Health Care Strong to Protect Kentucky’s Most Vulnerable Patients
Kentucky’s hospitals and health care community has faced tremendous challenges throughout the Covid-19 pandemic. Many are now dealing with financial losses brought on by increased costs to prepare for fighting the virus as well as the elimination of most non-essential services during the height of the pandemic. This entire situation has had an outsized impact…
Sen. McConnell: Help Ease Burden on Kentucky Hospitals
By Susan Murphy, PhD Kentucky’s health care providers have been put to the test throughout the COVID-19 pandemic. Despite facing massive losses due to suspending everything but the most essential services while preparing for a surge of COVID-19 cases, providers continued to serve our most vulnerable citizens. Now, however, overly stringent federal loan repayment terms…
Pfizer Outlines Five-Point Plan to Battle COVID-19
Pharmaceutical manufacturer Pfizer issued a five-point plan calling on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19. Dr. Albert Bourla, Chairman and CEO, made the following statement: “In this troubling time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic. Many companies, including…